about
Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetinLocalization and upregulation of survivin in cancer health disparities: a clinical perspectiveValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travel'Race' and prostate cancer mortality in equal-access healthcare systemsCancer incidence among capacitor manufacturing workers exposed to polychlorinated biphenylsMaximal testosterone suppression in the management of recurrent and metastatic prostate cancerIn Silico Analysis of the deleterious nsSNP's (missense) in the Homeobox domain of human HOXB13 gene responsible for hereditary prostate cancer.Physician role in physical activity for African-American males undergoing radical prostatectomy for prostate cancer.Early detection of prostate cancer: AUA Guideline.Evaluation of 99mTc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapseValidation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.Sunlight exposure during leisure activities and risk of prostate cancer in Montréal, Canada, 2005-2009.Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors.1-stearoylglycerol is associated with risk of prostate cancer: results from serum metabolomic profiling.Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.Prostate cancer in young men: an important clinical entity.A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer.Gleason 6 Prostate Cancer: Translating Biology into Population Health.Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment.Functional status declines among cancer survivors: trajectory and contributing factors.Generalizability of established prostate cancer risk variants in men of African ancestryBlack and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West AfricaAspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.Feasibility study of computed vs measured high b-value (1400 s/mm²) diffusion-weighted MR images of the prostate.Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) studyThioredoxin 1 in Prostate Tissue Is Associated with Gleason Score, Erythrocyte Antioxidant Enzyme Activity, and Dietary Antioxidants.Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions.The Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy.Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer.Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.Vasectomy and the risk of prostate cancer: a meta-analysis of cohort studies.A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.Trends in prostate cancer in the United States.Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells.Dietary Total Antioxidant Capacity is Inversely Associated with Prostate Cancer Aggressiveness in a Population-Based Study.A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.
P2860
Q24568189-5F13440B-9F54-48D5-A84B-1F5FF0E4BB10Q26799719-C829BE6E-E038-4407-9291-275FBA1F9A79Q27001399-AC6763FA-A241-4B64-8267-52A4582D2F11Q27008227-09C65C47-C858-47DA-BB46-B1B68A757208Q28469445-2F21345C-F6AF-4E2F-91D8-E2B27C2747C0Q29994552-33E4DB81-CC26-4AED-A2F4-4EA03FDD11DFQ30397277-EBFA0151-E35A-4ED3-B2FF-B16D7FAB1708Q30839649-64822ED3-3CD9-4F07-BC33-2F355A3545B8Q33608474-D0E451CB-169B-4E82-B4E6-4B6344358824Q33668676-F09A72DB-C040-4EB9-980A-42A6E8F6AC93Q33898869-533784D5-37AC-484A-964D-1825240475E3Q34006846-04070F1E-58D0-4D68-B47D-FFB10A091060Q34145479-8E342F1F-958C-47C0-8FBE-87772BDBEBBEQ34218543-17809427-35D7-4E69-B282-579FBFED2673Q34302881-096B982E-EAEE-4D69-92CF-92AB9C2C4D97Q34314644-32FC0A49-F8C0-491D-9047-84A2FF4FCF88Q34340561-3087E881-B59B-4ED9-A3FC-F896791D9FF4Q34460302-0BAB816B-7E4D-4B79-A3AF-D4DB1EA4D396Q34470640-8673B931-A288-4265-91C1-1F80A107085CQ34615270-7764B8E2-B667-4E04-AA99-9DEE5C3F55F7Q34623432-9A36C314-1E6A-41CF-84E8-77099D195863Q34716723-310C50E1-D1F5-49A2-AF72-A31E0B3DCEFDQ34728048-204D33FA-FE19-4A52-901B-853EC93123E1Q35010094-385CA5D2-6287-47D7-9F58-13DCF7CDD971Q35136401-AF6DF8B9-3590-4CF1-9FE4-C650E9B6F275Q35197378-5FC7F9D4-54DC-4350-85EB-2A0FD15A65A8Q35582133-356AAA3C-F192-46FE-BBD5-0EDEF6AF480BQ35957484-9FB484AA-C5E7-46F6-9EA7-F386265243A5Q36016027-DF3705CE-4A02-4867-86C1-7E7D95A2CE7DQ36060809-452FE54B-D0C3-4842-945B-A509045AF798Q36065460-D5A8A0C6-174C-4C18-96CE-142218FC4F77Q36202488-403E7E0C-C4AF-4695-9082-320EFDEDC243Q36250649-3604DE60-41A6-4111-9FE8-AC357221F702Q36402883-7D33E908-0D75-4D8F-B1CF-228C971DAE47Q36411680-743595B0-097C-478E-A9C3-F873E22183B6Q36462972-365EC711-A004-40A4-BFD0-997F6EB973D5Q36520517-7353837E-ED32-4448-8853-64F755345159Q36544125-9C7F2BCA-5660-4B27-A4D2-020C4CDA55F8Q36767975-8D9EA19C-79A2-4A1F-A645-1360B51EE105Q36776738-FD289D9D-3ED6-46BA-97C8-14BF226D0F70
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prostate cancer epidemiology in the United States.
@en
type
label
Prostate cancer epidemiology in the United States.
@en
prefLabel
Prostate cancer epidemiology in the United States.
@en
P2860
P1476
Prostate cancer epidemiology in the United States.
@en
P2093
Otis W Brawley
P2860
P2888
P304
P356
10.1007/S00345-012-0824-2
P577
2012-04-05T00:00:00Z
P6179
1015914980